Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 14

    1.

    Pneumocephalus secondary to removal of an osteoma from the paranasal sinuses of a horse.

    Ragle CA, de Mira MC, Pearson LK, Coelho JC.

    J Am Vet Med Assoc. 2009 Jul 15;235(2):184-8.PMID: 19601740 [PubMed - indexed for MEDLINE]Related articles

    2.

    Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.

    de Haas SL, de Visser SJ, van der Post JP, de Smet M, Schoemaker RC, Rijnbeek B, Cohen AF, Vega JM, Agrawal NG, Goel TV, Simpson RC, Pearson LK, Li S, Hesney M, Murphy MG, van Gerven JM.

    J Psychopharmacol. 2007 Jun;21(4):374-83. Epub 2006 Nov 8.PMID: 17092968 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients.

    Slatter JG, Schaaf LJ, Sams JP, Feenstra KL, Johnson MG, Bombardt PA, Cathcart KS, Verburg MT, Pearson LK, Compton LD, Miller LL, Baker DS, Pesheck CV, Lord RS 3rd.

    Drug Metab Dispos. 2000 Apr;28(4):423-33.PMID: 10725311 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Pharmacokinetics and tolerability of a novel 5-HT1D agonist, PNU-142633F.

    Fleishaker JC, Pearson LK, Knuth DW, Gomez-Mancilla B, Francom SF, McIntosh MJ, Freestone S, Azie NE.

    Int J Clin Pharmacol Ther. 1999 Oct;37(10):487-92.PMID: 10543315 [PubMed - indexed for MEDLINE]Related articles

    5.

    Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3A.

    Fleishaker JC, Pearson LK, Pearson PG, Wienkers LC, Hopkins NK, Peters GR.

    J Clin Pharmacol. 1999 Mar;39(3):260-7.PMID: 10073325 [PubMed - indexed for MEDLINE]Related articles

    6.

    Biotransformation of tirilazad in human: 4. effect of finasteride on tirilazad clearance and reduced metabolite formation.

    Fleishaker JC, Pearson PG, Wienkers LC, Pearson LK, Moore TA, Peters GR.

    J Pharmacol Exp Ther. 1998 Nov;287(2):591-7.PMID: 9808685 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Induction of tirilazad clearance by phenytoin.

    Fleishaker JC, Pearson LK, Peters GR.

    Biopharm Drug Dispos. 1998 Mar;19(2):91-6.PMID: 9533108 [PubMed - indexed for MEDLINE]Related articles

    8.

    Biotransformation of tirilazad in human: 2. Effect of ketoconazole on tirilazad clearance and oral bioavailability.

    Fleishaker JC, Pearson PG, Wienkers LC, Pearson LK, Peters GR.

    J Pharmacol Exp Ther. 1996 May;277(2):991-8.PMID: 8627582 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of the pharmacokinetics of tirilazad mesylate in healthy volunteers and stable subjects with mild liver cirrhosis.

    Pearson LK, Fleishaker JC, Peters GR.

    Eur J Clin Pharmacol. 1996;50(4):299-304.PMID: 8803523 [PubMed - indexed for MEDLINE]Related articles

    10.

    Gender does not affect the degree of induction of tirilazad clearance by phenobarbital.

    Fleishaker JC, Pearson LK, Peters GR.

    Eur J Clin Pharmacol. 1996;50(1-2):139-45.PMID: 8739825 [PubMed - indexed for MEDLINE]Related articles

    11.

    Phenytoin causes a rapid increase in 6 beta-hydroxycortisol urinary excretion in humans--a putative measure of CYP3A induction.

    Fleishaker JC, Pearson LK, Peters GR.

    J Pharm Sci. 1995 Mar;84(3):292-4.PMID: 7616365 [PubMed - indexed for MEDLINE]Related articles

    12.

    The Influence of Temperature on the Nature of the Fat formed by Living Organisms.

    Pearson LK, Raper HS.

    Biochem J. 1927;21(4):875-9. No abstract available. PMID: 16743914 [PubMed]Related articlesFree article

    13.

    The Preparation and Properties of Purified Oleic Acid and some of its Salts.

    Lapworth A, Pearson LK, Mottram EN.

    Biochem J. 1925;19(1):7-18. No abstract available. PMID: 16743474 [PubMed]Related articlesFree article

    14.

    Supplemental Content

    Find related data

    Search details

    » See more...